US20010000346A1 - Process for determining respiratory phases of the sleep of a user - Google Patents

Process for determining respiratory phases of the sleep of a user Download PDF

Info

Publication number
US20010000346A1
US20010000346A1 US09/732,873 US73287300A US2001000346A1 US 20010000346 A1 US20010000346 A1 US 20010000346A1 US 73287300 A US73287300 A US 73287300A US 2001000346 A1 US2001000346 A1 US 2001000346A1
Authority
US
United States
Prior art keywords
user
nasal
state
sleep
respiratory
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
US09/732,873
Other versions
US6409676B2 (en
Inventor
Stephane Ruton
Benoit Jonquet
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to US09/732,873 priority Critical patent/US6409676B2/en
Publication of US20010000346A1 publication Critical patent/US20010000346A1/en
Application granted granted Critical
Publication of US6409676B2 publication Critical patent/US6409676B2/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M16/00Devices for influencing the respiratory system of patients by gas treatment, e.g. mouth-to-mouth respiration; Tracheal tubes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/08Detecting, measuring or recording devices for evaluating the respiratory organs
    • A61B5/087Measuring breath flow
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/08Detecting, measuring or recording devices for evaluating the respiratory organs
    • A61B5/087Measuring breath flow
    • A61B5/09Measuring breath flow using an element rotated by the flow
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/72Signal processing specially adapted for physiological signals or for diagnostic purposes
    • A61B5/7235Details of waveform analysis
    • A61B5/7264Classification of physiological signals or data, e.g. using neural networks, statistical classifiers, expert systems or fuzzy systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M16/00Devices for influencing the respiratory system of patients by gas treatment, e.g. mouth-to-mouth respiration; Tracheal tubes
    • A61M16/0057Pumps therefor
    • A61M16/0066Blowers or centrifugal pumps
    • A61M16/0069Blowers or centrifugal pumps the speed thereof being controlled by respiratory parameters, e.g. by inhalation
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M16/00Devices for influencing the respiratory system of patients by gas treatment, e.g. mouth-to-mouth respiration; Tracheal tubes
    • A61M16/021Devices for influencing the respiratory system of patients by gas treatment, e.g. mouth-to-mouth respiration; Tracheal tubes operated by electrical means
    • A61M16/022Control means therefor
    • A61M16/024Control means therefor including calculation means, e.g. using a processor
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M16/00Devices for influencing the respiratory system of patients by gas treatment, e.g. mouth-to-mouth respiration; Tracheal tubes
    • A61M16/0003Accessories therefor, e.g. sensors, vibrators, negative pressure
    • A61M2016/0015Accessories therefor, e.g. sensors, vibrators, negative pressure inhalation detectors
    • A61M2016/0018Accessories therefor, e.g. sensors, vibrators, negative pressure inhalation detectors electrical
    • A61M2016/0021Accessories therefor, e.g. sensors, vibrators, negative pressure inhalation detectors electrical with a proportional output signal, e.g. from a thermistor
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M16/00Devices for influencing the respiratory system of patients by gas treatment, e.g. mouth-to-mouth respiration; Tracheal tubes
    • A61M16/0003Accessories therefor, e.g. sensors, vibrators, negative pressure
    • A61M2016/0027Accessories therefor, e.g. sensors, vibrators, negative pressure pressure meter
    • GPHYSICS
    • G16INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16HHEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H50/00ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
    • G16H50/20ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for computer-aided diagnosis, e.g. based on medical expert systems
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A90/00Technologies having an indirect contribution to adaptation to climate change
    • Y02A90/10Information and communication technologies [ICT] supporting adaptation to climate change, e.g. for weather forecasting or climate simulation

Definitions

  • the invention relates to a device and to a process for determining respiratory phases of the sleep of a user.
  • Respiratory disorders of sleep such as the Sleep Apnoea Syndrome (SAS) are characterized, in general, by a disfunctioning of the respiratory function during sleep.
  • SAS Sleep Apnoea Syndrome
  • Respiratory disorders may be of the obstructive or central type.
  • muscle control is absent (central apnoea) or diminished (central hypopnoea), the upper airways being open.
  • Obstructive disorders represent the great majority of nocturnal respiratory disorders.
  • cardio-respiratory function electrocardiogram, respiratory frequency, nasal and/or buccal flow, thoracic and abdominal movements, arterial oxygen saturation, snoring.
  • the treatment of respiratory sleep disorders customarily employs an appliance for keeping the upper airways open.
  • This appliance usually comprises a mask-based positive pressure apparatus (CPAP), in which a means of compressing the ambient air, operated by a control device, delivers air pressure to a pipe and then to a mask placed on the patient's nose in a leaktight manner.
  • CPAP mask-based positive pressure apparatus
  • the control device compares the value of the pressure in the mask with a set pressure target value and, depending on the deviation measured, adjusts a control signal which it delivers to the means for compressing the ambient air.
  • the pressure target value to be applied in the mask of the patient is determined empirically in the sleep laboratory by progressively increasing an initial target value and observing the consequences for the respiratory disorders, the value chosen being the first value for which normal unfragmented sleep is observed.
  • diagnosis and/or subsequent treatment may be incorrect or incomplete.
  • the aims of the present invention are therefore to propose a process and an apparatus for diagnosing and/or treating respiratory sleep disorders:
  • the subject of the invention is a device for determining respiratory phases of the sleep of a user, comprising means for measuring at least two physical variables of which at least a first physical variable is representative of the nasal flow of the user and of which at least a second physical variable is representative of the user's buccal flow, characterized in that it furthermore comprises means for processing and converting each physical variable with a view to establishing its degree of membership in at least one state of a fuzzy variable, and means for applying pre-established rules between at least one state of a first fuzzy variable and a state of a second fuzzy variable so as to evaluate the degree of membership in a respiratory phase state of the sleep of the user according to fuzzy logic.
  • each fuzzy variable possesses at least two states
  • the said states of respiratory phases of sleep comprise at least one state of normal respiration, a state of apnoea and a state of hypopnoea,
  • the degrees of membership of the states associated with a fuzzy variable are established on the basis of continuous curves defined over the entire universe of discourse of a measured physical variable
  • the measurement means comprise a pressure sensor linked to a nose piece intended to be worn by the user and one of the measured physical variables is the pressure signal measured by the said pressure sensor,
  • the said processing and conversion means comprise means for extracting from the measured pressure signal snoring phases associated with breathing-obstruction phenomena
  • the said means for extracting snoring phases comprise means of high-pass filtering of the pressure signal, means for amplifying the filtered signal, means for interpolating the said amplified filtered signal so as to obtain an envelope curve, means for storing a reference curve and means for comparing the said envelope curve with the said reference curve so as to determine the presence of snoring phases,
  • the measurement means comprise a current sensor measuring the current consumed by a low-inertia turbine which is linked to the said nose piece and one of the measured physical variables is the current consumed by the said turbine,
  • the processing and conversion means comprise means for extracting from the signal of current consumed an image of the nasal flow of the user, means for determining the phases of nasal inhalation and exhalation of the said user, means for calculating the time derivative of the amplitude of the nasal flow during an inhalation phase and means for utilizing the derivative so as to determine whether the user is or is not suffering from a partial obstructive phenomenon,
  • the said means for utilizing the derivative of the amplitude of the nasal flow comprise means for comparing the absolute value of the derivative with at least one reference value and means for measuring the duration for which the absolute value of the derivative is less than the said at least one reference value,
  • the said means for utilizing the derivative furthermore comprise means for charting the number of changes of sign of the derivative when the latter is less than the reference value
  • the measurement means comprise a member for measuring the resistance of a thermistor intended to be placed in proximity to the mouth of the said user, and one of the measured physical variables is the resistance measured by the said member for measuring the resistance of the thermistor.
  • the subject of the invention is also a process for determining respiratory phases of the sleep of a user, characterized in that it comprises the following steps:
  • At least two physical variables are measured, of which at least a first physical variable is representative of the nasal flow of the user and of which at least a second physical variable is representative of the user's buccal flow,
  • each physical variable is processed and converted with a view to establishing its degree of membership in at least one state of a fuzzy variable
  • pre-established rules between at least one state of a first fuzzy variable and a state of a second fuzzy variable are applied so as to evaluate the degree of membership in a respiratory phase state of the sleep of the user according to fuzzy logic.
  • each fuzzy variable possesses at least two states
  • the said states of respiratory phases of sleep comprise at least one state of normal respiration, a state of apnoea and a state of hypopnoea,
  • one of the measured physical variables is the pressure in a nose piece worn by the user
  • the current consumed by a low-inertia turbine which is linked to the said nose piece worn by the user is for example measured
  • the phases of inhalation and exhalation of the said user are determined and the time derivative of the amplitude of the nasal flow during an inhalation phase is calculated and this derivative thus calculated is utilized to determine whether or not the user is suffering from a partial obstructive phenomenon
  • the absolute value of this derivative is compared with at least one reference value, and the duration for which the absolute value of the derivative is less than the said at least one reference value is measured,
  • the resistance of a thermistor placed in proximity to the said user's mouth is for example measured.
  • the subject of the invention is also a method for diagnosing the respiratory phases of the sleep of a patient suffering from respiratory sleep disorders, in particular sleep apnoea, characterized in that it comprises the following steps:
  • At least two physical variables are measured, of which at least a first physical variable is representative of the nasal flow of the user and of which at least a second physical variable is representative of the user's buccal flow,
  • each physical variable is processed and converted with a view to establishing its degree of membership in at least one state of a fuzzy variable
  • pre-established rules between at least one state of a first fuzzy variable and a state of a second fuzzy variable are applied so as to evaluate the degree of membership in a respiratory phase state of the sleep of the user according to fuzzy logic.
  • each fuzzy variable possesses at least two states
  • the said states of respiratory phases of sleep comprise at least one state of normal respiration, a state of apnoea and a state of hypopnoea,
  • the degrees of membership of the states associated with a fuzzy variable are established on the basis of continuous curves defined over the entire universe of discourse of a measured physical variable
  • one of the measured physical variables is the pressure in a nose piece worn by the user
  • the current consumed by a low-inertia turbine which is linked to the said nose piece worn by the patient is for example measured
  • the phases of inhalation and exhalation of the said patient are determined and the time derivative of the amplitude of the nasal flow during an inhalation phase is calculated and this derivative thus calculated is utilized to determine whether or not the patient is suffering from a partial obstructive phenomenon
  • the absolute value of this derivative is compared with at least one reference value, and the duration for which the absolute value of the derivative is less than the said at least one reference value is measured,
  • the resistance of a thermistor placed in proximity to the said patient's mouth is for example measured.
  • FIG. 1 is a schematic diagram of a device according to the invention
  • FIG. 2 is a flowchart showing certain steps in the processing of a physical variable representative of the nasal flow of a user
  • FIG. 3 shows two graphs to illustrate in particular the steps described with reference to FIG. 2,
  • FIG. 4 represents a graph showing a nasal flow as a function of time in the case where the user's respiratory passages are impaired by partial obstruction
  • FIG. 5 represents a graph showing the time derivative of the nasal flow of FIG. 4,
  • FIG. 6 shows two graphs to illustrate the determination of a snoring phenomenon from a pressure signal measured at the nose piece and/or mouthpiece applied to the user
  • FIG. 7 shows a graph to illustrate the conversion of a measured physical variable with a view to establishing its degrees of membership in one or more states of a fuzzy variable.
  • FIG. 1 Represented in FIG. 1 is a device 1 according to the invention making it possible to determine respiratory phases of the sleep of a user 3 .
  • This device 1 comprises means 5 for measuring at least two physical variables, of which at least a first physical variable is representative of the nasal flow of the user and of which at least a second physical variable is representative of the user's buccal flow.
  • the user 3 wears a mouth- and/or nose-piece 7 , such as a mask and/or breathing kit which are known per se and will not be described in detail here.
  • a mouth- and/or nose-piece 7 such as a mask and/or breathing kit which are known per se and will not be described in detail here.
  • a low-inertia turbine 9 To this nose/mouth piece 7 is connected a low-inertia turbine 9 by means of a breathing pipe 11 making it possible to convey the pressurized breathing gas to the respiratory passages of the user 3 .
  • the breathing gas is dispensed at a positive pressure which is constant over time, that is to say at a single pressure level (CPAP type apparatus), or at a pressure which varies between at least one low pressure level and at least one higher pressure level, that is to say at several pressure levels (BPAP type apparatus)
  • CPAP type apparatus a positive pressure which is constant over time
  • BPAP type apparatus a pressure which varies between at least one low pressure level and at least one higher pressure level
  • BPAP type apparatus a pressure which varies between at least one low pressure level and at least one higher pressure level
  • a pressure sensor 13 whose pressure tap point is arranged on the nose/mouth piece 7 , that is to say in immediate proximity to the respiratory passages of the user 3 , makes it possible to detect the pressure variations due to the breathing of the user.
  • This sensor 13 is linked to means 15 controlling the turbine 9 so as to supply these means 15 with a pressure signal.
  • these means 15 supply a control signal to the turbine 9 in such a way as to modulate the overpressure supplied by the turbine 9 to the user 3 (see also EP-A-505232 or U.S. Pat. No. 5,443,061).
  • a current sensor 17 measures the current consumed by the turbine 9 .
  • a sensor such as for example a thermistor (not visible in the figure) is placed in the mouth/nose piece in immediate proximity to the mouth of the user 3 ,
  • This sensor for example the abovementioned thermistor, is linked to a measurement member 19 measuring, in the case of a thermistor, the resistance of the latter.
  • the measurement value such as, for example, the resistance of the thermistor is modified by temperature variations caused by any buccal flow issuing from the mouth of the user 3 , thereby making it possible to obtain an image of the buccal flow which is reliable and accurate.
  • the device 1 furthermore comprises means 21 for processing and converting each physical variable charted with a view to establishing its degree of membership in at least one state of a fuzzy variable.
  • the degrees of membership of the respective states of the fuzzy variables are input into means 23 for applying rules stored in a memory 25 forming a knowledge base.
  • the processing and conversion means 21 comprise means 27 for extracting from the signal of current consumed, measured by the current sensor 17 , an image of the nasal flow of the user 3 , that is to say the variation of the nasal flow over time.
  • This image of the nasal flow of the user 3 is input into means 29 for determining the phases of nasal inhalation and exhalation of the user, into means 30 for determining the amplitude of the nasal flow and into means 31 for calculating the time derivative of the amplitude of the nasal flow.
  • the means 30 furthermore receive a control signal for the means 29 indicating which phase of respiration the user is in.
  • the means 31 only calculate the derivative of the nasal flow during an inhalation phase. This is why the means 29 also send a control signal to the means 31 for calculating the derivative when they have determined that the user is in a nasal inhalation phase.
  • the derivative calculated by the means 31 is input into utilizing means 33 .
  • These utilizing means 33 comprise means 35 for comparing the absolute value of the derivative with at least one reference value recorded in a memory 37 . Depending on the result of the comparison, the means 35 activate means 39 for measuring the duration for which the absolute value of the derivative is less than the said at least one reference value.
  • the means 33 comprise, linked to the means 31 for calculating the derivative as well as to the comparison means 35 , means 41 for charting the number of changes of sign of the derivative when the absolute value of the latter is less than the reference value.
  • the means 33 for utilizing the derivative of the amplitude of the nasal flow are employed to determine whether or not the user is suffering from a partial obstruction of the respiratory passages, as will be explained in detail hereinbelow.
  • the processing and conversion means 21 furthermore comprise means 42 for processing the signal delivered by the member 19 for measuring for example the resistance of the thermistor.
  • processing and conversion means 21 comprise means 43 for extracting from the pressure signal, measured by the pressure sensor 13 , snoring phases associated with breathing-obstruction phenomena.
  • These extraction means 43 comprise means 45 of high-pass filtering of the pressure signal, means 47 for amplifying the filtered signal, means 49 for interpolating the said amplified filtered signal so as to obtain an envelope curve, means 51 for storing a reference curve and means 53 for comparing the said envelope curve with the said reference curve so as to determine the presence of snoring phases.
  • the various physical variables thus processed are input into means 55 for converting each of these variables with view to establishing its degree of membership in at least one state of an associated fuzzy variable.
  • This conversion which will be explained in greater detail below, is carried out on the basis of continuous curves defined over the entire universe of discourse of the physical variables stored in a database 57 linked to the conversion means 55 .
  • FIG. 2 Represented in FIG. 2 are the main operating steps implemented by the means 27 and 29 .
  • the average M 1 of eighty sampled values is calculated, this corresponding to an average of the measurement values over a duration of 20 seconds. This duration of 20s corresponds to two or three breathing cycles of the user.
  • the average M 2 of five sampled values is calculated, this corresponding to an average of the measurement values over a duration of 125 milliseconds and being in fact the almost raw signal, slightly smoothed.
  • the nasal flow F nasal is calculated as the difference between M 2 and M 1 .
  • F nasal is compared with respective thresholds S inhal and S exhal .
  • the thresholds S inhal and S exhal correspond to values representative of the rate of flow of the nasal flow respectively above or below which it is almost certain that the user is in a phase of inhalation or exhalation. Of course S inhal is greater than S exhal .
  • the thresholds S inhal and S exhal can be determined empirically by clinical trials on users.
  • FIG. 3 shows two graphs of which one, the upper graph, shows a curve 78 of the nasal flow F nasal as a function of time and the other, the lower graph, shows a curve 80 of the values of the variable cycle which are allocated to this variable as a function of the value of the nasal flow F nasal .
  • the duration of the user's breathing cycles is determined.
  • the potential ranges of sleep hypopnoea and apnoea are determined since these phenomena are regarded as occurring only for prolonged nasal exhalation phases, typically for exhalation phases having a duration of greater than 3 seconds.
  • the user is, onwards of the instant t 0 , in a nasal exhalation phase.
  • the user is again in the nasal exhalation phase and therefore in a potential time range of sleep hypopnoea or apnoea.
  • the means 30 determine, during an inhalation phase, the maximum of the nasal flow F nasal (bearing the reference number 82 ) and during an exhalation phase the minimum of the nasal flow F nasal (bearing the reference number 84 ), and calculate the difference between this maximum and this minimum.
  • the means 30 receive from the means 29 a control signal so as to calculate the amplitude of the nasal flow at each second, that is to say to calculate the difference between the nasal flow determined at a given instant and that at an instant preceding it by, for example, one second.
  • this determination at closely-spaced intervals of time of the amplitude of the nasal flow is implemented by the means 30 onwards of the instant t 1 .
  • a normal breathing cycle possesses a sinusoidal shape as represented in FIG. 3 up to the instant t 0 .
  • the inhalatory flow which increases at the start of an inhalation phase is rapidly limited so that the curved F nasal possesses a clipped form.
  • Such a curve 82 of F nasal as a function of time in the case of a limiting rate of flow is represented by way of example in the graph of FIG. 4.
  • the means 31 calculate, during an inhalation phase, the time derivative of the amplitude of the nasal flow F nasal , represented by the curve 84 of FIG. 5.
  • the means 39 measure the duration ⁇ t DL for which the absolute value of the derivative is less than the reference value V R .
  • ⁇ t DL is greater than a threshold duration lying for example between one and two seconds, it is possible to conclude that the user is suffering from a partial obstructive phenomenon. This diagnosis is reinforced when the sign of the derivative changes many times during ⁇ t DL .
  • the determination of the amplitude A buccal of the buccal flow F buccal by the means 42 for processing the signal delivered by the member 19 for qualitative measurement of the rate of flow, for example by measurement of the resistance of a thermistor, is similar to that of the amplitude A nasal for the nasal flow F nasal .
  • the difference between the maximum and the minimum of the buccal flow F buccal is calculated.
  • the amplitude A buccal is determined only during a phase of prolonged nasal exhalation, that is to say one having a duration of greater than 3 seconds.
  • the means 42 received from the means 29 a control signal so as to calculate the amplitude of the buccal flow at each second, that is to say to calculate the difference between the buccal flow determined at a given instant and that at an instant preceding it by, for example, one second.
  • Snoring is characteristic of an obstructive phenomenon in the respiratory passages of a user. At the level of the pressure signal measured by the sensor 13 , it is manifested by oscillations which are superimposed on the normal pressure signal as is represented in the upper graph of FIG. 6 showing by way of example a curve 90 representative of snoring.
  • a high-pass filtering of the pressure signal is firstly carried out in the means 45 and the filtered signal is amplified in the means 47 .
  • the filtered and amplified signal is represented as a function of time by the curve 92 in the lower graph of FIG. 6.
  • the amplified filtered signal is interpolated by way of the means 49 so as to obtain an envelope curve 94 .
  • This envelope curve 94 passes through all the maxima of the filtered and amplified signal and, in the case of snoring, exhibits a characteristic shape, This is why this envelope curve 94 is then compared in the means 53 with the reference curve recorded in the storage means 51 so as to determine the presence of snoring phases.
  • FIG. 7 Represented in FIG. 7 is a graph showing, along the abscissa, the universe of discourse of the nasal flow A nasal and, along the ordinate, the membership values of states of the associated fuzzy variable A f nasal .
  • the fuzzy variable A f nasal can take four states, namely the states called “low”, “medium-low”, “medium-high” and “high”.
  • curve 100 is associated with the “low” state and exhibits the shape of a plateau following by a negative slope.
  • Curve 102 is associated with the “medium-low” state and exhibits a trapezium shape.
  • Curve 104 is associated with the “medium-high” state and exhibits a triangular shape, and curve 106 is associated with the “high” state and exhibits a positive slope followed by a plateau.
  • the ordinate values of the curves 100 , 102 , 104 and 106 lie between zero (0) and one (1).
  • the states together with their respective degrees of membership of the fuzzy variables are input into means 23 for applying rules stored in the memory 25 forming a knowledge base. These rules are defined empirically from clinical trials on users.
  • Each rule involves at least two different fuzzy variables to obtain for example a degree of membership in a state of a phase of sleep respiration of the user 3 .
  • fuzzy variable A f nasal As well as the fuzzy variable A f buccal .
  • This fuzzy variable A f buccal can also take four states, namely the states referred to as “low”, “medium-low”, “medium-high” and “high”, and the degrees of membership in these states are established from the amplitude of the buccal flow A buccal when the duration of the exhalation phase is greater than three seconds. Phase of No.
  • the means 23 apply rules 1 to 11 in the following manner so as to determine the phases of respiration according to fuzzy logic.
  • the means 23 consider only the relevant rules, that is to say those rules for which a degree of membership is assigned to a state of the first fuzzy variable and a degree of membership is assigned to a state of the second fuzzy variable. In the present example, these are rules No. 5, 6, 8 and 9.
  • a “MIN-MAX” selection order is applied. This order consists in assigning, initially, to a respiratory phase, associated with a specified rule, a degree of membership equal to the minimum of the degrees of membership of the states of the said fuzzy variables which are to be considered in respect of this specified rule.
  • fuzzy logic makes it possible to refine the diagnosis of the respiratory phases of a user.
  • processing and conversion means 21 as well as the means 23 for applying rules and the memory 25 are embodied mainly through a computer comprising interfaces adapted for capturing the signals from the sensors 13 , 17 and 19 and loaded with programs adapted for processing and utilizing these signals.

Abstract

A process for determining respiratory phases of the sleep of a user (3), comprising measuring at least two physical variables of which at least a first physical variable is representative of the nasal flow of the user (3) and of which at least a second physical variable is representative of the user's buccal flow. The process furthermore comprises processing and converting each physical variable with a view to establishing its degree of membership in at least one state of a fuzzy variable, and applying pre-established rules between at least one state of a first fuzzy variable and a state of a second fuzzy variable so as to evaluate the degree of membership in a respiratory phase state of the sleep of the user (3) according to fuzzy logic.

Description

  • 1. The invention relates to a device and to a process for determining respiratory phases of the sleep of a user.
  • 2. Respiratory disorders of sleep, such as the Sleep Apnoea Syndrome (SAS) are characterized, in general, by a disfunctioning of the respiratory function during sleep.
  • 3. Considerable fragmentation of sleep is observed in subjects affected by such a syndrome, with short phases of sleep and the resumption of normal respiration usually accompanied by a brief period of wakefulness, lasting a few seconds.
  • 4. The normal course of sleep, from the stage of light sleep to the stage of deep sleep, via a stage of paradoxical sleep, is greatly disturbed, this having consequences on the daytime routine of these subjects. Thus, they tend to be drowsy, or even to fall asleep when fully active, and a decrease in intellectual and sexual functions is also observed in them, together with the risks of hypertension and cardiac insufficiency.
  • 5. Respiratory disorders may be of the obstructive or central type.
  • 6. In the first case, a total obstruction (obstructive apnoea) or partial obstruction (obstructive hypopnoea) of the upper airways is observed while muscular effort is maintained. Disorders of this type are often associated with considerable snoring.
  • 7. In the second case, muscle control is absent (central apnoea) or diminished (central hypopnoea), the upper airways being open.
  • 8. Obstructive disorders represent the great majority of nocturnal respiratory disorders.
  • 9. Customarily, diagnosis of respiratory sleep disorders is performed in a sleep laboratory by recording and studying numerous parameters related:
  • 10. either to sleep: electroencephalogram, electroocculogram, electromyogram,
  • 11. or to cardio-respiratory function: electrocardiogram, respiratory frequency, nasal and/or buccal flow, thoracic and abdominal movements, arterial oxygen saturation, snoring.
  • 12. Diagnosis of these sleep pathologies is recent and its implementation is unwieldy and requires that the subject be hospitalized for one or two nights.
  • 13. The treatment of respiratory sleep disorders customarily employs an appliance for keeping the upper airways open.
  • 14. This appliance usually comprises a mask-based positive pressure apparatus (CPAP), in which a means of compressing the ambient air, operated by a control device, delivers air pressure to a pipe and then to a mask placed on the patient's nose in a leaktight manner.
  • 15. The control device compares the value of the pressure in the mask with a set pressure target value and, depending on the deviation measured, adjusts a control signal which it delivers to the means for compressing the ambient air.
  • 16. At present, the pressure target value to be applied in the mask of the patient is determined empirically in the sleep laboratory by progressively increasing an initial target value and observing the consequences for the respiratory disorders, the value chosen being the first value for which normal unfragmented sleep is observed.
  • 17. There are apparatuses for diagnosing or/and treating these nocturnal respiratory disorders, which detect apnoeas or hypopnoeas, but do not differentiate between central and obstructive events.
  • 18. Others, after having detected an apnoea, send a pressure pulse to the patient's mask and study any echo: if there is no echo, the event is central, and if an echo returns, the event is obstructive.
  • 19. Such apparatuses are described in particular in the documents FR-A-2663547 and FR-A-2674133.
  • 20. However, in order to be able to establish a correct diagnosis of respiratory disorders (apnoeas, hypopnoeas, pathology of increased resistance, etc.) and/or to determine and/or initiate adequate and effective treatment, it may be necessary or even vital for the practitioner, that is to say the doctor or the like, to have a reliable image representative of the succession of the various inhalatory and exhalatory phases of his patient, that is to say the image of the subject's respiratory flow or rate of flow.
  • 21. However, existing processes and apparatuses do not allow this kind of reliable and accurate determination of the image of the said respiratory rate of flow.
  • 22. Henceforth, it is readily understood that diagnosis and/or subsequent treatment may be incorrect or incomplete.
  • 23. The aims of the present invention are therefore to propose a process and an apparatus for diagnosing and/or treating respiratory sleep disorders:
  • 24. which are able to allow the reliable and accurate determination, from various respiration parameters for a patient, of the latter's various respiratory phases,
  • 25. which are able to determine accurately the phases of snoring and/or phenomena with a partial obstruction of the patient's respiratory passages,
  • 26. which can be used both in a sleep laboratory, that is to say in a hospital environment, and also at the patient's home, and
  • 27. which have a reasonable cost.
  • 28. To this end, the subject of the invention is a device for determining respiratory phases of the sleep of a user, comprising means for measuring at least two physical variables of which at least a first physical variable is representative of the nasal flow of the user and of which at least a second physical variable is representative of the user's buccal flow, characterized in that it furthermore comprises means for processing and converting each physical variable with a view to establishing its degree of membership in at least one state of a fuzzy variable, and means for applying pre-established rules between at least one state of a first fuzzy variable and a state of a second fuzzy variable so as to evaluate the degree of membership in a respiratory phase state of the sleep of the user according to fuzzy logic.
  • 29. The device according to the invention can additionally comprise one or more of the following characteristics:
  • 30. each fuzzy variable possesses at least two states,
  • 31. the said states of respiratory phases of sleep comprise at least one state of normal respiration, a state of apnoea and a state of hypopnoea,
  • 32. the degrees of membership of the states associated with a fuzzy variable are established on the basis of continuous curves defined over the entire universe of discourse of a measured physical variable,
  • 33. the measurement means comprise a pressure sensor linked to a nose piece intended to be worn by the user and one of the measured physical variables is the pressure signal measured by the said pressure sensor,
  • 34. the said processing and conversion means comprise means for extracting from the measured pressure signal snoring phases associated with breathing-obstruction phenomena,
  • 35. the said means for extracting snoring phases comprise means of high-pass filtering of the pressure signal, means for amplifying the filtered signal, means for interpolating the said amplified filtered signal so as to obtain an envelope curve, means for storing a reference curve and means for comparing the said envelope curve with the said reference curve so as to determine the presence of snoring phases,
  • 36. the measurement means comprise a current sensor measuring the current consumed by a low-inertia turbine which is linked to the said nose piece and one of the measured physical variables is the current consumed by the said turbine,
  • 37. the processing and conversion means comprise means for extracting from the signal of current consumed an image of the nasal flow of the user, means for determining the phases of nasal inhalation and exhalation of the said user, means for calculating the time derivative of the amplitude of the nasal flow during an inhalation phase and means for utilizing the derivative so as to determine whether the user is or is not suffering from a partial obstructive phenomenon,
  • 38. the said means for utilizing the derivative of the amplitude of the nasal flow comprise means for comparing the absolute value of the derivative with at least one reference value and means for measuring the duration for which the absolute value of the derivative is less than the said at least one reference value,
  • 39. the said means for utilizing the derivative furthermore comprise means for charting the number of changes of sign of the derivative when the latter is less than the reference value,
  • 40. the measurement means comprise a member for measuring the resistance of a thermistor intended to be placed in proximity to the mouth of the said user, and one of the measured physical variables is the resistance measured by the said member for measuring the resistance of the thermistor.
  • 41. The subject of the invention is also a process for determining respiratory phases of the sleep of a user, characterized in that it comprises the following steps:
  • 42. at least two physical variables are measured, of which at least a first physical variable is representative of the nasal flow of the user and of which at least a second physical variable is representative of the user's buccal flow,
  • 43. each physical variable is processed and converted with a view to establishing its degree of membership in at least one state of a fuzzy variable, and
  • 44. pre-established rules between at least one state of a first fuzzy variable and a state of a second fuzzy variable are applied so as to evaluate the degree of membership in a respiratory phase state of the sleep of the user according to fuzzy logic.
  • 45. This process can moreover comprise one or more of the following characteristics:
  • 46. each fuzzy variable possesses at least two states,
  • 47. the said states of respiratory phases of sleep comprise at least one state of normal respiration, a state of apnoea and a state of hypopnoea,
  • 48. the degrees of membership of the states associated with a fuzzy variable are established on the basis of continuous curves defined over the entire universe of discourse of a measured physical variable,
  • 49. one of the measured physical variables is the pressure in a nose piece worn by the user,
  • 50. during the processing and conversion, snoring phases associated with breathing-obstruction phenomena are extracted from the measured pressure signal,
  • 51. during extraction, high-pass filtering of the pressure signal is carried out, the filtered signal is amplified, the said amplified filtered signal is interpolated so as to obtain an envelope curve, and the said envelope curve is compared with a reference curve so as to determine the presence of snoring phases,
  • 52. to obtain an image of the nasal flow, the current consumed by a low-inertia turbine which is linked to the said nose piece worn by the user is for example measured,
  • 53. during extraction of the said image of the nasal flow, the phases of inhalation and exhalation of the said user are determined and the time derivative of the amplitude of the nasal flow during an inhalation phase is calculated and this derivative thus calculated is utilized to determine whether or not the user is suffering from a partial obstructive phenomenon,
  • 54. during utilization of the derivative of the amplitude of the nasal flow, the absolute value of this derivative is compared with at least one reference value, and the duration for which the absolute value of the derivative is less than the said at least one reference value is measured,
  • 55. during utilization of the derivative of the amplitude of the nasal flow, the number of changes of sign of the derivative when the absolute value of the latter is less than the said at least one reference value is moreover charted,
  • 56. to obtain an image of the buccal flow, the resistance of a thermistor placed in proximity to the said user's mouth is for example measured.
  • 57. The subject of the invention is also a method for diagnosing the respiratory phases of the sleep of a patient suffering from respiratory sleep disorders, in particular sleep apnoea, characterized in that it comprises the following steps:
  • 58. at least two physical variables are measured, of which at least a first physical variable is representative of the nasal flow of the user and of which at least a second physical variable is representative of the user's buccal flow,
  • 59. each physical variable is processed and converted with a view to establishing its degree of membership in at least one state of a fuzzy variable, and
  • 60. pre-established rules between at least one state of a first fuzzy variable and a state of a second fuzzy variable are applied so as to evaluate the degree of membership in a respiratory phase state of the sleep of the user according to fuzzy logic.
  • 61. This process can additionally comprise one or more of the following characteristics:
  • 62. each fuzzy variable possesses at least two states,
  • 63. the said states of respiratory phases of sleep comprise at least one state of normal respiration, a state of apnoea and a state of hypopnoea,
  • 64. the degrees of membership of the states associated with a fuzzy variable are established on the basis of continuous curves defined over the entire universe of discourse of a measured physical variable,
  • 65. one of the measured physical variables is the pressure in a nose piece worn by the user,
  • 66. during the processing and conversion, snoring phases associated with breathing-obstruction phenomena are extracted from the measured pressure signal,
  • 67. during extraction, high-pass filtering of the pressure signal is carried out, the filtered signal is amplified, the said amplified filtered signal is interpolated so as to obtain an envelope curve, and the said envelope curve is compared with a reference curve so as to determine the presence of snoring phases,
  • 68. to obtain an image of the nasal flow, the current consumed by a low-inertia turbine which is linked to the said nose piece worn by the patient is for example measured,
  • 69. during extraction of the said image of the nasal flow, the phases of inhalation and exhalation of the said patient are determined and the time derivative of the amplitude of the nasal flow during an inhalation phase is calculated and this derivative thus calculated is utilized to determine whether or not the patient is suffering from a partial obstructive phenomenon,
  • 70. during utilization of the derivative of the amplitude of the nasal flow, the absolute value of this derivative is compared with at least one reference value, and the duration for which the absolute value of the derivative is less than the said at least one reference value is measured,
  • 71. during utilization of the derivative of the amplitude of the nasal flow, the number of changes of sign of the derivative when the absolute value of the latter is less than the said at least one reference value is moreover charted,
  • 72. to obtain an image of the buccal flow, the resistance of a thermistor placed in proximity to the said patient's mouth is for example measured.
  • 73. Other characteristics and advantages of the invention will emerge from the following description given by way of example, without limiting character, with regard to the appended drawings in which:
  • 74.FIG. 1 is a schematic diagram of a device according to the invention,
  • 75.FIG. 2 is a flowchart showing certain steps in the processing of a physical variable representative of the nasal flow of a user,
  • 76.FIG. 3 shows two graphs to illustrate in particular the steps described with reference to FIG. 2,
  • 77.FIG. 4 represents a graph showing a nasal flow as a function of time in the case where the user's respiratory passages are impaired by partial obstruction,
  • 78.FIG. 5 represents a graph showing the time derivative of the nasal flow of FIG. 4,
  • 79.FIG. 6 shows two graphs to illustrate the determination of a snoring phenomenon from a pressure signal measured at the nose piece and/or mouthpiece applied to the user, and
  • 80.FIG. 7 shows a graph to illustrate the conversion of a measured physical variable with a view to establishing its degrees of membership in one or more states of a fuzzy variable.
  • 81. 1. Structure of the device according to the invention
  • 82. Represented in FIG. 1 is a device 1 according to the invention making it possible to determine respiratory phases of the sleep of a user 3.
  • 83. This device 1 comprises means 5 for measuring at least two physical variables, of which at least a first physical variable is representative of the nasal flow of the user and of which at least a second physical variable is representative of the user's buccal flow.
  • 84. To this end, the user 3 wears a mouth- and/or nose-piece 7, such as a mask and/or breathing kit which are known per se and will not be described in detail here.
  • 85. To this nose/mouth piece 7 is connected a low-inertia turbine 9 by means of a breathing pipe 11 making it possible to convey the pressurized breathing gas to the respiratory passages of the user 3.
  • 86. As the case may be, the breathing gas is dispensed at a positive pressure which is constant over time, that is to say at a single pressure level (CPAP type apparatus), or at a pressure which varies between at least one low pressure level and at least one higher pressure level, that is to say at several pressure levels (BPAP type apparatus) The manner of operation of such apparatuses having already been described many times in the prior art, it will not be detailed hereinbelow. However, for further details, reference may be made in particular to the following documents: U.S. Pat. No. 5,492,113, U.S. Pat. No. 5,239,995, EP-A-0 656 216 or EP-A-0 505 232.
  • 87. A pressure sensor 13 whose pressure tap point is arranged on the nose/mouth piece 7, that is to say in immediate proximity to the respiratory passages of the user 3, makes it possible to detect the pressure variations due to the breathing of the user. This sensor 13 is linked to means 15 controlling the turbine 9 so as to supply these means 15 with a pressure signal. On the basis of the pressure signal received and of a specified overpressure target value, these means 15 supply a control signal to the turbine 9 in such a way as to modulate the overpressure supplied by the turbine 9 to the user 3 (see also EP-A-505232 or U.S. Pat. No. 5,443,061).
  • 88. Given that the pressure of the breathing gas supplied to the user must be almost constant, it is understood that the motor speed of the said turbine 9 and therefore the amount of current consumed by the latter is dependent on the control signal of the means 15 and therefore corresponds to the nasal flow of the user 3.
  • 89. This is why, to obtain an image of the nasal flow, a current sensor 17 measures the current consumed by the turbine 9.
  • 90. Moreover, in order to supplement the image of the nasal flow with an image of the buccal flow, a sensor such as for example a thermistor (not visible in the figure) is placed in the mouth/nose piece in immediate proximity to the mouth of the user 3,
  • 91. This sensor, for example the abovementioned thermistor, is linked to a measurement member 19 measuring, in the case of a thermistor, the resistance of the latter.
  • 92. In effect, the measurement value such as, for example, the resistance of the thermistor is modified by temperature variations caused by any buccal flow issuing from the mouth of the user 3, thereby making it possible to obtain an image of the buccal flow which is reliable and accurate.
  • 93. To determine the respiratory phases of the sleep of the user 3 from the values of the physical variables measured by way of the sensors 13, 19 and 17, that is to say the images of the pressure, of the nasal flow and of the buccal flow, the device 1 furthermore comprises means 21 for processing and converting each physical variable charted with a view to establishing its degree of membership in at least one state of a fuzzy variable. The degrees of membership of the respective states of the fuzzy variables are input into means 23 for applying rules stored in a memory 25 forming a knowledge base.
  • 94. The processing and conversion means 21 comprise means 27 for extracting from the signal of current consumed, measured by the current sensor 17, an image of the nasal flow of the user 3, that is to say the variation of the nasal flow over time. This image of the nasal flow of the user 3 is input into means 29 for determining the phases of nasal inhalation and exhalation of the user, into means 30 for determining the amplitude of the nasal flow and into means 31 for calculating the time derivative of the amplitude of the nasal flow.
  • 95. The means 30 furthermore receive a control signal for the means 29 indicating which phase of respiration the user is in.
  • 96. The means 31 only calculate the derivative of the nasal flow during an inhalation phase. This is why the means 29 also send a control signal to the means 31 for calculating the derivative when they have determined that the user is in a nasal inhalation phase.
  • 97. The derivative calculated by the means 31 is input into utilizing means 33. These utilizing means 33 comprise means 35 for comparing the absolute value of the derivative with at least one reference value recorded in a memory 37. Depending on the result of the comparison, the means 35 activate means 39 for measuring the duration for which the absolute value of the derivative is less than the said at least one reference value.
  • 98. Moreover, the means 33 comprise, linked to the means 31 for calculating the derivative as well as to the comparison means 35, means 41 for charting the number of changes of sign of the derivative when the absolute value of the latter is less than the reference value.
  • 99. The means 33 for utilizing the derivative of the amplitude of the nasal flow are employed to determine whether or not the user is suffering from a partial obstruction of the respiratory passages, as will be explained in detail hereinbelow.
  • 100. The processing and conversion means 21 furthermore comprise means 42 for processing the signal delivered by the member 19 for measuring for example the resistance of the thermistor.
  • 101. Additionally, the processing and conversion means 21 comprise means 43 for extracting from the pressure signal, measured by the pressure sensor 13, snoring phases associated with breathing-obstruction phenomena.
  • 102. These extraction means 43 comprise means 45 of high-pass filtering of the pressure signal, means 47 for amplifying the filtered signal, means 49 for interpolating the said amplified filtered signal so as to obtain an envelope curve, means 51 for storing a reference curve and means 53 for comparing the said envelope curve with the said reference curve so as to determine the presence of snoring phases.
  • 103. The various physical variables thus processed are input into means 55 for converting each of these variables with view to establishing its degree of membership in at least one state of an associated fuzzy variable. This conversion, which will be explained in greater detail below, is carried out on the basis of continuous curves defined over the entire universe of discourse of the physical variables stored in a database 57 linked to the conversion means 55.
  • 104. II. Manner of operation of the device according to the invention
  • 105. The manner of operation of the device 1 according to the invention will be explained hereinbelow while setting forth in detail on the one hand the various processing and conversion steps implemented in the processing and conversion means 21, and on the other hand the implementing of the application of the rules to the fuzzy variables by the means 23 according to fuzzy logic.
  • 106. II.1 Determination of the phases of nasal inhalation and exhalation of the user as well as of the amplitude of the nasal flow
  • 107. Represented in FIG. 2 are the main operating steps implemented by the means 27 and 29.
  • 108. During a first step 60, the signal of current consumed by the turbine 9, delivered by the current sensor 17, is input into the extraction means 27 and is then digitized there and sampled at a rate of Δts=25 ms during a second step 62.
  • 109. Next, during a step 64, the average M1 of eighty sampled values is calculated, this corresponding to an average of the measurement values over a duration of 20 seconds. This duration of 20s corresponds to two or three breathing cycles of the user.
  • 110. In parallel with this, during a step 66, the average M2 of five sampled values is calculated, this corresponding to an average of the measurement values over a duration of 125 milliseconds and being in fact the almost raw signal, slightly smoothed.
  • 111. During a next step 68, the nasal flow Fnasal is calculated as the difference between M2 and M1.
  • 112. Then, during steps 70 and 72, Fnasal is compared with respective thresholds Sinhal and Sexhal. The thresholds Sinhal and Sexhal correspond to values representative of the rate of flow of the nasal flow respectively above or below which it is almost certain that the user is in a phase of inhalation or exhalation. Of course Sinhal is greater than Sexhal. The thresholds Sinhal and Sexhal can be determined empirically by clinical trials on users.
  • 113. If, during step 70, Fnasal is greater than the threshold Sinhal, the value one is allocated during a step 74 to a variable named cycle, cycle=1 therefore signifying that the user 3 is in a nasal inhalation phase, and then we return to step 62. If Fnasal is less than the threshold value Sinhal, we return directly to step 62.
  • 114. If, during the comparison step 72, Fnasal is less than Sexhal, then the value zero is allocated during step 76 to the variable cycle, cycle=0 signifying that the user 3 is in a nasal exhalation phase, and then we return to step 62. If Fnasal is greater than the threshold value Sexhal, we return directly to step 62.
  • 115. These steps making it possible to determine the phases of nasal inhalation and exhalation of the user are illustrated in FIG. 3. This FIG. 3 shows two graphs of which one, the upper graph, shows a curve 78 of the nasal flow Fnasal as a function of time and the other, the lower graph, shows a curve 80 of the values of the variable cycle which are allocated to this variable as a function of the value of the nasal flow Fnasal.
  • 116. In this figure, it is clearly seen that as soon as Fnasal exceeds the threshold Sinhal, cycle takes the value 1, and if Fnasal is less than Sexhal, cycle takes the value 0. Up to the instant referenced to it is possible to regard the user having a normal breathing cycle.
  • 117. Beyond t0, Fnasal no longer manages, after entering an exhalation phase, to exceed Sinhal and cycle remains at the value 0. This may be due to buccal respiration of the user, but also to sleep hypopnoea or apnoea.
  • 118. Furthermore, by measuring the time between the start of two inhalation phases (cycle=1), the duration of the user's breathing cycles is determined. By measuring the duration of the exhalation phases, the potential ranges of sleep hypopnoea and apnoea are determined since these phenomena are regarded as occurring only for prolonged nasal exhalation phases, typically for exhalation phases having a duration of greater than 3 seconds. For example, in FIG. 3 the user is, onwards of the instant t0, in a nasal exhalation phase. Onwards of the instant t1, 3s later than t0, the user is again in the nasal exhalation phase and therefore in a potential time range of sleep hypopnoea or apnoea.
  • 119. Additionally, to calculate the amplitude of the nasal flow Anasal the means 30 determine, during an inhalation phase, the maximum of the nasal flow Fnasal (bearing the reference number 82) and during an exhalation phase the minimum of the nasal flow Fnasal (bearing the reference number 84), and calculate the difference between this maximum and this minimum.
  • 120. During a prolonged exhalation phase, that is to say one having for example a duration of greater than 3 seconds, the means 30 receive from the means 29 a control signal so as to calculate the amplitude of the nasal flow at each second, that is to say to calculate the difference between the nasal flow determined at a given instant and that at an instant preceding it by, for example, one second. In FIG. 3, this determination at closely-spaced intervals of time of the amplitude of the nasal flow is implemented by the means 30 onwards of the instant t1.
  • 121. II.2 Determination of an obstructive respiratory event termed “limiting rate of flow”
  • 122. A normal breathing cycle possesses a sinusoidal shape as represented in FIG. 3 up to the instant t0. In the case of a partial obstruction of the user's respiratory passages, the inhalatory flow which increases at the start of an inhalation phase, is rapidly limited so that the curved Fnasal possesses a clipped form. Such a curve 82 of Fnasal as a function of time in the case of a limiting rate of flow is represented by way of example in the graph of FIG. 4.
  • 123. In order to be able to detect such phenomenon accurately, the means 31 calculate, during an inhalation phase, the time derivative of the amplitude of the nasal flow Fnasal, represented by the curve 84 of FIG. 5.
  • 124. The absolute value of the time derivative thus calculated is compared at each instant by the means 35 with a reference value VR recorded in the memory 37. Of course, it is also possible to make provision for several reference values if this proves necessary.
  • 125. Furthermore, controlled by the comparison means 35, the means 39 measure the duration ΔtDL for which the absolute value of the derivative is less than the reference value VR.
  • 126. Additionally, during ΔtDL the means 41 chart the number of changes of sign of the derivative.
  • 127. From the moment that ΔtDL is greater than a threshold duration lying for example between one and two seconds, it is possible to conclude that the user is suffering from a partial obstructive phenomenon. This diagnosis is reinforced when the sign of the derivative changes many times during ΔtDL.
  • 128. II.3 Determination of the amplitude of the buccal flow of the user
  • 129. The determination of the amplitude Abuccal of the buccal flow Fbuccal by the means 42 for processing the signal delivered by the member 19 for qualitative measurement of the rate of flow, for example by measurement of the resistance of a thermistor, is similar to that of the amplitude Anasal for the nasal flow Fnasal. In effect, after some smoothing of the raw signal and the subtracting of an offset, the difference between the maximum and the minimum of the buccal flow Fbuccal is calculated.
  • 130. Preferably, so as to reduce the calculation and processing steps, the amplitude Abuccal is determined only during a phase of prolonged nasal exhalation, that is to say one having a duration of greater than 3 seconds. In this case, that is to say onwards of the instant t1 represented in FIG. 3, the means 42 received from the means 29 a control signal so as to calculate the amplitude of the buccal flow at each second, that is to say to calculate the difference between the buccal flow determined at a given instant and that at an instant preceding it by, for example, one second.
  • 131. II.4 Determination of a phase of snoring of the user
  • 132. Snoring is characteristic of an obstructive phenomenon in the respiratory passages of a user. At the level of the pressure signal measured by the sensor 13, it is manifested by oscillations which are superimposed on the normal pressure signal as is represented in the upper graph of FIG. 6 showing by way of example a curve 90 representative of snoring.
  • 133. To determine whether the user 3 is suffering from snoring, a high-pass filtering of the pressure signal is firstly carried out in the means 45 and the filtered signal is amplified in the means 47. The filtered and amplified signal is represented as a function of time by the curve 92 in the lower graph of FIG. 6.
  • 134. Next, the amplified filtered signal is interpolated by way of the means 49 so as to obtain an envelope curve 94. This envelope curve 94 passes through all the maxima of the filtered and amplified signal and, in the case of snoring, exhibits a characteristic shape, This is why this envelope curve 94 is then compared in the means 53 with the reference curve recorded in the storage means 51 so as to determine the presence of snoring phases.
  • 135. II.5 Conversion of the processed physical variables into states of fuzzy variables with degrees of membership
  • 136. By way of example, explained in detail below is the conversion of a processed physical variable, the amplitude of the nasal flow Anasal when the duration of the nasal exhalation phase is greater than three seconds, so as to establish its degree of membership in one or more states of an associated fuzzy variable, called Af nasal this conversion procedure is applied in a similar manner to all the other physical variables to be taken into account for applying rules according to fuzzy logic.
  • 137. Represented in FIG. 7 is a graph showing, along the abscissa, the universe of discourse of the nasal flow Anasal and, along the ordinate, the membership values of states of the associated fuzzy variable Af nasal.
  • 138. As may be seen in the figure, the fuzzy variable Af nasal can take four states, namely the states called “low”, “medium-low”, “medium-high” and “high”.
  • 139. With each state of Af nasal there is associated a continuous curve 100, 102, 104 and 106 making it possible to establish the degree of membership of a value of Anasal in one or more states of the fuzzy variable Af nasal.
  • 140. Thus for example, curve 100 is associated with the “low” state and exhibits the shape of a plateau following by a negative slope. Curve 102 is associated with the “medium-low” state and exhibits a trapezium shape. Curve 104 is associated with the “medium-high” state and exhibits a triangular shape, and curve 106 is associated with the “high” state and exhibits a positive slope followed by a plateau.
  • 141. The shape of the curves 100, 102, 104 and 106 is defined empirically from clinical trials on users. It is noted that the plateaus at the ends of the universe of discourse of the physical variables are generally retained.
  • 142. Furthermore, the ordinate values of the curves 100, 102, 104 and 106 lie between zero (0) and one (1).
  • 143. Moreover, it is important to note that the various curves 100, 102, 104 and 106 overlap in such a way that a value of Anasal can belong to two states of Af nasal.
  • 144. Thus for example the value Anasal=0.1 belongs to
  • 145. a “low” state of the fuzzy variable Af nasal with a degree of membership of 0.1, and
  • 146. a “medium-low” state of the fuzzy variable Af nasal with a degree of membership of 0.9.
  • 147. This is also represented in FIG. 7.
  • 148. These other physical variables are converted by the conversion means 55 according to the same principle.
  • 149. II.6 Application of rules to the states of fuzzy variables with degrees of membership
  • 150. The states together with their respective degrees of membership of the fuzzy variables are input into means 23 for applying rules stored in the memory 25 forming a knowledge base. These rules are defined empirically from clinical trials on users.
  • 151. Each rule involves at least two different fuzzy variables to obtain for example a degree of membership in a state of a phase of sleep respiration of the user 3.
  • 152. By way of example, indicated below is a suite of eleven rules for two fuzzy variables, the abovementioned fuzzy variable Af nasal as well as the fuzzy variable Af buccal. This fuzzy variable Af buccal can also take four states, namely the states referred to as “low”, “medium-low”, “medium-high” and “high”, and the degrees of membership in these states are established from the amplitude of the buccal flow Abuccal when the duration of the exhalation phase is greater than three seconds.
    Phase of
    No. Af buccal Af nasal respiration
    1 medium-high medium-high normal
    2 low medium-high hypopnoea
    3 medium-low medium-high hypopnoea
    4 medium-high low hypopnoea
    5 low low apnoea
    6 medium-low low hypopnoea
    7 medium-high medium-low hypopnoea
    8 low medium-low hypopnoea
    9 medium-low medium-low hypopnoea
    10 high normal
    11 high normal
  • 153. Let us assume that Anasal belongs to
  • 154. a “low” state of the fuzzy variable Af nasal with a degree of membership of 0.1, and
  • 155. a “medium-low” state of the fuzzy variable Af nasal with a degree of membership 0.9,
  • 156. and that Abuccal belongs to
  • 157. a “low” state of the fuzzy variable Af buccal with a degree of membership of 0.7, and
  • 158. a “medium-low” state of the fuzzy variable Af buccal with a degree of membership 0.2.
  • 159. The means 23 apply rules 1 to 11 in the following manner so as to determine the phases of respiration according to fuzzy logic.
  • 160. Initially, the means 23 consider only the relevant rules, that is to say those rules for which a degree of membership is assigned to a state of the first fuzzy variable and a degree of membership is assigned to a state of the second fuzzy variable. In the present example, these are rules No. 5, 6, 8 and 9.
  • 161. Next, a “MIN-MAX” selection order is applied. This order consists in assigning, initially, to a respiratory phase, associated with a specified rule, a degree of membership equal to the minimum of the degrees of membership of the states of the said fuzzy variables which are to be considered in respect of this specified rule.
  • 162. In the present example, by applying for example rule No. 5, we find that the sleep of the user 3 is in an “apnoea” respiratory phase with a degree of membership equal to MIN (0.7; 0.1)=0.1.
  • 163. Similarly, by applying rule No. 6 we find that the sleep of the user 3 is in a “hypopnoea” respiratory phase with a degree of membership equal to MIN (0.2; 0.1)=0.1, by applying rule No. 8, in a “hypopnoea” respiratory phase with a degree of membership equal to MIN (0.7; 0.9)=0.7, and by applying rule No. 9, in a “hypopnoea” respiratory phase with a degree of membership equal to MIN (0.2; 0.9)=0.2.
  • 164. As final result of the degrees of membership of the respective states of the respiratory phases of the sleep of the user according to fuzzy logic, consideration is subsequently given to the maximum membership value obtained for each state, namely in the present example 0 for the state of normal respiration, 0.1 for the state of apnoea respiration and 0.7 for the state of hypopnoea respiration.
  • 165. Thus, it is understood that the use of fuzzy logic makes it possible to refine the diagnosis of the respiratory phases of a user.
  • 166. Advantageously, the processing and conversion means 21 as well as the means 23 for applying rules and the memory 25 are embodied mainly through a computer comprising interfaces adapted for capturing the signals from the sensors 13, 17 and 19 and loaded with programs adapted for processing and utilizing these signals.

Claims (14)

What is claimed is:
1. A process for determining respiratory phases of the sleep of a user, comprising:
measuring at least two physical variables of which at least a first physical variable is representative of the nasal flow of the user, and of which at least a second physical variable is representative of the user's buccal flow;
processing and converting each physical variable with a view to establishing its degree of membership in at least one state of a fuzzy variable; and
applying pre-established rules between at least one state of a first fuzzy variable and a state of a second fuzzy variable so as to evaluate the degree of membership in a respiratory phase state of the sleep of the user according to fuzzy logic.
2. The process according to
claim 1
, wherein the respiratory state comprises at least one of a state of normal respiration, a state of apnea and a state of hypopnea.
3. The process according to
claim 1
, wherein each fuzzy variable possesses at least two states.
4. The process according to
claim 1
, wherein the degrees of membership of the states associated with a fuzzy variable are established on the basis of continuous curves defined over the entire universe of discourse of a measured physical variable.
5. The processing according to
claim 1
, wherein one of the measured physical variables is a pressure signal measured by a pressure sensor linked to a nose piece worn by the user.
6. The process according to
claim 5
, further comprising, during the step of processing and converting, extracting from the measured pressure signal snoring phases associated with breathing-obstruction phenomena.
7. The process according to
claim 6
, further comprising high-pass filtering of the pressure signal during extraction to obtain a filtered signal; amplifying the filtered signal to obtain an amplified filtered signal; interpolating the amplified filtered signal so as to obtain an envelope curve; and comparing the envelope curve with the reference curve so as to determine the presence of snoring phases.
8. The process according to
claim 1
, further comprising measuring the current consumed by a low-inertia turbine linked to a nose piece intended to be worn by the user to obtain an image of the nasal flow of the user.
9. The process according to
claim 8
, further comprising determining the phases of nasal inhalation and exhalation of the user during extraction; calculating the time derivative of the amplitude of the nasal flow during an inhalation phase; and utilizing the derivative so as to determine whether the user is or is not suffering from a partial obstructive phenomenon.
10. The process according to
claim 9
, wherein the step of utilizing the derivative of the amplitude of the nasal flow comprises comparing the absolute value of the derivative with at least one reference value, and measuring the duration for which the absolute value of the derivative is less than said at least one reference value.
11. The process according to
claim 10
, wherein the step of utilizing the derivative comprises charting the number of charges of sign of the derivative when the latter is less than the reference value.
12. The process according to
claim 1
, further comprising measuring the resistance of a thermistor placed in proximity to the mouth of the user to obtain an image of the buccal flow of the user.
13. Method for diagnosing the respiratory phases of the sleep of a patient suffering from respiratory sleep disorders, wherein said respiratory phases are determined according to the process according to
claim 1
.
14. Method for diagnosing according to
claim 13
, wherein the respiratory sleep disorder is sleep apnea or hypopnea.
US09/732,873 1998-06-18 2000-12-11 Process for determining respiratory phases of the sleep of a user Expired - Fee Related US6409676B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
US09/732,873 US6409676B2 (en) 1998-06-18 2000-12-11 Process for determining respiratory phases of the sleep of a user

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
FR9807695 1998-06-18
FR9807695A FR2779932B1 (en) 1998-06-18 1998-06-18 DEVICE FOR DETERMINING RESPIRATORY PHASES OF THE SLEEP OF A USER
US09/335,724 US6190328B1 (en) 1998-06-18 1999-06-18 Device for determining respiratory phases of the sleep of a user
US09/732,873 US6409676B2 (en) 1998-06-18 2000-12-11 Process for determining respiratory phases of the sleep of a user

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
US09/335,724 Division US6190328B1 (en) 1998-06-18 1999-06-18 Device for determining respiratory phases of the sleep of a user

Publications (2)

Publication Number Publication Date
US20010000346A1 true US20010000346A1 (en) 2001-04-19
US6409676B2 US6409676B2 (en) 2002-06-25

Family

ID=9527546

Family Applications (2)

Application Number Title Priority Date Filing Date
US09/335,724 Expired - Fee Related US6190328B1 (en) 1998-06-18 1999-06-18 Device for determining respiratory phases of the sleep of a user
US09/732,873 Expired - Fee Related US6409676B2 (en) 1998-06-18 2000-12-11 Process for determining respiratory phases of the sleep of a user

Family Applications Before (1)

Application Number Title Priority Date Filing Date
US09/335,724 Expired - Fee Related US6190328B1 (en) 1998-06-18 1999-06-18 Device for determining respiratory phases of the sleep of a user

Country Status (7)

Country Link
US (2) US6190328B1 (en)
EP (1) EP0965306A1 (en)
JP (1) JP2000023926A (en)
AR (1) AR018900A1 (en)
BR (1) BR9917147A (en)
CA (1) CA2275209A1 (en)
FR (1) FR2779932B1 (en)

Cited By (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050038353A1 (en) * 2003-08-14 2005-02-17 Rapoport David M. Positive airway pressure system and method for treatment of sleeping disorder in patient
US20050061320A1 (en) * 2003-09-18 2005-03-24 Cardiac Pacemakers, Inc. Coordinated use of respiratory and cardiac therapies for sleep disordered breathing
US20050074741A1 (en) * 2003-09-18 2005-04-07 Kent Lee System and method for discrimination of central and obstructive disordered breathing events
US20050256420A1 (en) * 2004-05-12 2005-11-17 Norman Robert G System and method for classifying patient's breathing using artificial neural network
US20070239056A1 (en) * 2006-03-28 2007-10-11 Kent Moore System and method of predicting efficacy of tongue-base therapies
US7524279B2 (en) 2003-12-31 2009-04-28 Raphael Auphan Sleep and environment control method and system
US20090198100A1 (en) * 2006-05-17 2009-08-06 Kent Moore Stereovideoscope and method of using the same
US7725195B2 (en) 2006-02-16 2010-05-25 Imthera Medical, Inc. RFID-based apparatus, system, and method for therapeutic treatment of obstructive sleep apnea
US7757690B2 (en) 2003-09-18 2010-07-20 Cardiac Pacemakers, Inc. System and method for moderating a therapy delivered during sleep using physiologic data acquired during non-sleep
US20100198103A1 (en) * 2007-10-09 2010-08-05 Imthera Medical, Inc. System and method for neural stimulation
US7787946B2 (en) 2003-08-18 2010-08-31 Cardiac Pacemakers, Inc. Patient monitoring, diagnosis, and/or therapy systems and methods
US7887493B2 (en) 2003-09-18 2011-02-15 Cardiac Pacemakers, Inc. Implantable device employing movement sensing for detecting sleep-related disorders
US20110069597A1 (en) * 2009-05-15 2011-03-24 Panasonic Corporation Optical head apparatus, holographic optical device, optical integrated device, optical information processing apparatus, and signal detection method
US8002553B2 (en) 2003-08-18 2011-08-23 Cardiac Pacemakers, Inc. Sleep quality data collection and evaluation
US8428725B2 (en) 2008-10-09 2013-04-23 Imthera Medical, Inc. Method of stimulating a Hypoglossal nerve for controlling the position of a patient's tongue
US8515535B2 (en) 2005-02-28 2013-08-20 Cardiac Pacemakers, Inc. Implantable cardiac device with dyspnea measurement
US20140000612A1 (en) * 2001-01-29 2014-01-02 Resmed R&D Germany Gmbh Apparatus and method for supplying a respiratory gas
US8886322B2 (en) 2009-11-10 2014-11-11 Imthera Medical, Inc. System for stimulating a hypoglossal nerve for controlling the position of a patient's tongue
US9358353B2 (en) 2007-05-11 2016-06-07 Resmed Limited Automated control for detection of flow limitation
US9585601B2 (en) 2013-08-15 2017-03-07 Chunyuan Qiu Systems, methods and devices for diagnosing sleep apnea
CN109715056A (en) * 2016-09-16 2019-05-03 斯派洛克斯公司 Diagnostic tool and application method
US11298074B2 (en) 2015-12-08 2022-04-12 Fisher & Paykel Healthcare Limited Flow-based sleep stage determination
US11957448B2 (en) 2023-04-04 2024-04-16 Spirox, Inc. Diagnostic tool and method of use

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050121033A1 (en) * 1998-02-25 2005-06-09 Ric Investments, Llc. Respiratory monitoring during gas delivery
FR2779932B1 (en) * 1998-06-18 2000-12-01 Taema DEVICE FOR DETERMINING RESPIRATORY PHASES OF THE SLEEP OF A USER
FR2794635B1 (en) * 1999-06-14 2001-08-03 Taema APPARATUS FOR DIAGNOSING OR TREATING SLEEP BREATHING DISORDERS AND METHOD OF OPERATION
US6739335B1 (en) * 1999-09-08 2004-05-25 New York University School Of Medicine Method and apparatus for optimizing controlled positive airway pressure using the detection of cardiogenic oscillations
US6910480B1 (en) * 1999-09-15 2005-06-28 Resmed Ltd. Patient-ventilator synchronization using dual phase sensors
AU778469B2 (en) * 1999-09-15 2004-12-09 Resmed Limited Patient-ventilator synchronization using dual phase sensors
DE10123060A1 (en) * 2001-05-11 2002-11-28 Univ Albert Ludwigs Freiburg Computer controlled device for identifying and classifying respiratory behavior due to breathing irregularities when asleep employs integrated monitoring unit
CA2704183A1 (en) * 2002-10-03 2004-04-15 Scott Laboratories, Inc. Neural networks in sedation and analgesia systems
US7189204B2 (en) 2002-12-04 2007-03-13 Cardiac Pacemakers, Inc. Sleep detection using an adjustable threshold
US7896812B2 (en) * 2003-08-14 2011-03-01 New York University System and method for diagnosis and treatment of a breathing pattern of a patient
US7396333B2 (en) 2003-08-18 2008-07-08 Cardiac Pacemakers, Inc. Prediction of disordered breathing
US20050142070A1 (en) * 2003-09-18 2005-06-30 Hartley Jesse W. Methods and systems for assessing pulmonary disease with drug therapy control
US7662101B2 (en) 2003-09-18 2010-02-16 Cardiac Pacemakers, Inc. Therapy control based on cardiopulmonary status
US8606356B2 (en) 2003-09-18 2013-12-10 Cardiac Pacemakers, Inc. Autonomic arousal detection system and method
SE0401207D0 (en) * 2004-05-10 2004-05-10 Breas Medical Ab Diagnostic system for disordered breathing
JP4686281B2 (en) * 2005-07-06 2011-05-25 株式会社東芝 Respiratory state determination device, respiratory state measurement method, and respiratory state determination program
CN100438827C (en) * 2006-01-23 2008-12-03 财团法人资讯工业策进会 Method of automation respiratory waveform interpretation based on ontology and system thereof
US7734350B2 (en) * 2006-06-14 2010-06-08 Zmed Technologies, Inc. Respiration apparatus
WO2007147046A2 (en) * 2006-06-14 2007-12-21 Zmed Technologies, Inc. Respiration stimulation
GB2440966A (en) * 2006-08-15 2008-02-20 Vb Uk Ip Ltd Determining the distance of visual fixation using measurements of the respiratory system and/or from eyelid function
NZ722192A (en) * 2010-07-30 2018-01-26 Resmed Ltd Methods and devices with leak detection
KR101696787B1 (en) * 2012-12-31 2017-01-16 연세대학교 원주산학협력단 Sleep-disordered breathing detection method and apparatus with continuous blood pressure signal measured during sleep
WO2015038666A1 (en) 2013-09-10 2015-03-19 Ahmad Samir S Zero pressure start continuous positive airway pressure therapy
JP2016028661A (en) * 2014-07-25 2016-03-03 船井電機株式会社 Snore detecting device
TW201615236A (en) * 2014-10-31 2016-05-01 台達電子工業股份有限公司 Breathing assistance apparatus having controllable gasbag and method for controlling the gasbag
WO2018089789A1 (en) 2016-11-10 2018-05-17 The Research Foundation For The State University Of New York System, method and biomarkers for airway obstruction
KR102309547B1 (en) * 2019-12-12 2021-10-08 강릉원주대학교산학협력단 Apparatus for analyzing breathing characteristics of snoring state and method thereof
KR102365405B1 (en) * 2020-04-09 2022-02-21 주식회사 애드에이블 Respiration training system using mobile game
KR102365413B1 (en) * 2020-04-09 2022-02-21 주식회사 애드에이블 Respiration training apparatus

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5522382A (en) * 1987-06-26 1996-06-04 Rescare Limited Device and method for treating obstructed breathing having a delay/ramp feature
GB2214302A (en) * 1988-01-11 1989-08-31 Nikolai Sleep Monitoring Clini An apnoea monitor for use during sleep
JP2794196B2 (en) * 1989-06-20 1998-09-03 チェスト株式会社 Apnea prevention stimulator
US5239995A (en) 1989-09-22 1993-08-31 Respironics, Inc. Sleep apnea treatment apparatus
FR2663547B1 (en) 1990-06-25 1997-10-10 Taema CONTINUOUS SUPPLY INSTALLATION OF BREATHING GAS PRESSURE.
FR2674133B1 (en) 1991-03-21 1993-06-11 Taema RESPIRATORY GAS PRESSURE SUPPLY SYSTEM AND METHOD FOR CONTROLLING SUCH A SYSTEM.
US5309921A (en) * 1992-02-11 1994-05-10 Spectrum Medical Technologies Apparatus and method for respiratory monitoring
AUPM279393A0 (en) 1993-12-03 1994-01-06 Rescare Limited Estimation of flow and detection of breathing in cpap treatment
US5772599A (en) * 1996-05-09 1998-06-30 Albert Einstein Healthcare Network Apparatus and method for monitoring a system
AUPO247496A0 (en) * 1996-09-23 1996-10-17 Resmed Limited Assisted ventilation to match patient respiratory need
FR2779932B1 (en) * 1998-06-18 2000-12-01 Taema DEVICE FOR DETERMINING RESPIRATORY PHASES OF THE SLEEP OF A USER

Cited By (57)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9827387B2 (en) * 2001-01-29 2017-11-28 Resmed R&D Germany Gmbh Apparatus and method for supplying a respiratory gas
US20140000612A1 (en) * 2001-01-29 2014-01-02 Resmed R&D Germany Gmbh Apparatus and method for supplying a respiratory gas
US20050038353A1 (en) * 2003-08-14 2005-02-17 Rapoport David M. Positive airway pressure system and method for treatment of sleeping disorder in patient
US6988994B2 (en) 2003-08-14 2006-01-24 New York University Positive airway pressure system and method for treatment of sleeping disorder in patient
US7787946B2 (en) 2003-08-18 2010-08-31 Cardiac Pacemakers, Inc. Patient monitoring, diagnosis, and/or therapy systems and methods
US8002553B2 (en) 2003-08-18 2011-08-23 Cardiac Pacemakers, Inc. Sleep quality data collection and evaluation
US9814429B2 (en) 2003-09-18 2017-11-14 Cardiac Pacemakers, Inc. System and method for discrimination of central and obstructive disordered breathing events
US7757690B2 (en) 2003-09-18 2010-07-20 Cardiac Pacemakers, Inc. System and method for moderating a therapy delivered during sleep using physiologic data acquired during non-sleep
US20050061320A1 (en) * 2003-09-18 2005-03-24 Cardiac Pacemakers, Inc. Coordinated use of respiratory and cardiac therapies for sleep disordered breathing
US7591265B2 (en) * 2003-09-18 2009-09-22 Cardiac Pacemakers, Inc. Coordinated use of respiratory and cardiac therapies for sleep disordered breathing
US20050074741A1 (en) * 2003-09-18 2005-04-07 Kent Lee System and method for discrimination of central and obstructive disordered breathing events
US7887493B2 (en) 2003-09-18 2011-02-15 Cardiac Pacemakers, Inc. Implantable device employing movement sensing for detecting sleep-related disorders
US8522779B2 (en) 2003-09-18 2013-09-03 Cardiac Pacemakers, Inc. Coordinated use of respiratory and cardiac therapies for sleep disordered breathing
US8104470B2 (en) 2003-09-18 2012-01-31 Cardiac Pacemakers, Inc. Coordinated use of respiratory and cardiac therapies for sleep disordered breathing
US8657756B2 (en) 2003-09-18 2014-02-25 Cardiac Pacemakers, Inc. Implantable device employing movement sensing for detecting sleep-related disorders
US7524279B2 (en) 2003-12-31 2009-04-28 Raphael Auphan Sleep and environment control method and system
US20050256420A1 (en) * 2004-05-12 2005-11-17 Norman Robert G System and method for classifying patient's breathing using artificial neural network
US7276031B2 (en) 2004-05-12 2007-10-02 New York University System and method for classifying patient's breathing using artificial neural network
US8954146B2 (en) 2005-02-28 2015-02-10 Cardiac Pacemakers, Inc. Implantable cardiac device with dyspnea measurement
US9277885B2 (en) 2005-02-28 2016-03-08 Cardiac Pacemakers, Inc. Implantable cardiac device with dyspnea measurement
US8515535B2 (en) 2005-02-28 2013-08-20 Cardiac Pacemakers, Inc. Implantable cardiac device with dyspnea measurement
US8750992B2 (en) 2005-02-28 2014-06-10 Cardiac Pacemakers, Inc. Implantable cardiac device with dyspnea measurement
US20110172733A1 (en) * 2006-02-16 2011-07-14 Imthera Medical, Inc. Apparatus, system and method for therapeutic treatment of obstructive sleep apnea
US7725195B2 (en) 2006-02-16 2010-05-25 Imthera Medical, Inc. RFID-based apparatus, system, and method for therapeutic treatment of obstructive sleep apnea
US7937159B2 (en) 2006-02-16 2011-05-03 Imthera Medical Inc. Apparatus, system and method for therapeutic treatment of obstructive sleep apnea
US20110213438A1 (en) * 2006-02-16 2011-09-01 Im Thera Medical, Inc. Apparatus, system, and method for therapeutic treatment of a patient
US20100198306A1 (en) * 2006-02-16 2010-08-05 Imthera Medical, Inc. apparatus, system and method for therapeutic treatment of obstructive sleep apnea
US7697968B2 (en) * 2006-03-28 2010-04-13 Kent Moore System and method of predicting efficacy of tongue-base therapies
US20070239056A1 (en) * 2006-03-28 2007-10-11 Kent Moore System and method of predicting efficacy of tongue-base therapies
US8162820B2 (en) 2006-05-17 2012-04-24 Kent Moore Stereovideoscope and method of using the same
US20090198100A1 (en) * 2006-05-17 2009-08-06 Kent Moore Stereovideoscope and method of using the same
US9358353B2 (en) 2007-05-11 2016-06-07 Resmed Limited Automated control for detection of flow limitation
US11717626B2 (en) 2007-05-11 2023-08-08 ResMed Pty Ltd Automated control for detection of flow limitation
US10549053B2 (en) 2007-05-11 2020-02-04 ResMed Pty Ltd Automated control for detection of flow limitation
US20100241195A1 (en) * 2007-10-09 2010-09-23 Imthera Medical, Inc. Apparatus, system and method for selective stimulation
US9884191B2 (en) 2007-10-09 2018-02-06 Imthera Medical, Inc. Apparatus, system, and method for selective stimulation
US9849288B2 (en) 2007-10-09 2017-12-26 Imthera Medical, Inc. Apparatus, system, and method for selective stimulation
US20100198103A1 (en) * 2007-10-09 2010-08-05 Imthera Medical, Inc. System and method for neural stimulation
US10646714B2 (en) 2007-10-09 2020-05-12 Imthera Medical, Inc. Apparatus, system, and method for selective stimulation
US11351364B2 (en) 2007-10-09 2022-06-07 Imthera Medical, Inc. Apparatus, system, and method for selective stimulation
US9579505B2 (en) 2008-10-09 2017-02-28 Imthera Medical, Inc. Method of stimulating a hypoglossal nerve for controlling the position of a patient's tongue
US8428725B2 (en) 2008-10-09 2013-04-23 Imthera Medical, Inc. Method of stimulating a Hypoglossal nerve for controlling the position of a patient's tongue
US8751005B2 (en) 2008-10-09 2014-06-10 Imthera Medical, Inc. Method of stimulating a hypoglossal nerve for controlling the position of a patients tongue
US10279185B2 (en) 2008-10-09 2019-05-07 Imthera Medical, Inc. Method of stimulating a hypoglossal nerve for controlling the position of a patient's tongue
US9314641B2 (en) 2008-10-09 2016-04-19 Imthera Medical, Inc. Method of stimulating a hypoglossal nerve for controlling the position of a patient's tongue
US9031654B2 (en) 2008-10-09 2015-05-12 Imthera Medical, Inc. Method of stimulating a hypoglossal nerve for controlling the position of a patient's tongue
US9895541B2 (en) 2008-10-09 2018-02-20 Imthera Medical, Inc. Method of stimulating a hypoglossal nerve for controlling the position of a patients tongue
US20110069597A1 (en) * 2009-05-15 2011-03-24 Panasonic Corporation Optical head apparatus, holographic optical device, optical integrated device, optical information processing apparatus, and signal detection method
US9339651B2 (en) 2009-11-10 2016-05-17 Imthera Medical, Inc. System for stimulating a hypoglossal nerve for controlling the position of a patient's tongue
US9662497B2 (en) 2009-11-10 2017-05-30 Imthera Medical, Inc System for stimulating a hypoglossal nerve for controlling the position of a patient's tongue
US8886322B2 (en) 2009-11-10 2014-11-11 Imthera Medical, Inc. System for stimulating a hypoglossal nerve for controlling the position of a patient's tongue
US10368800B2 (en) 2013-08-15 2019-08-06 Chunyuan Qiu Systems, methods and devices for diagnosing sleep apnea
US9585601B2 (en) 2013-08-15 2017-03-07 Chunyuan Qiu Systems, methods and devices for diagnosing sleep apnea
US11298074B2 (en) 2015-12-08 2022-04-12 Fisher & Paykel Healthcare Limited Flow-based sleep stage determination
CN109715056A (en) * 2016-09-16 2019-05-03 斯派洛克斯公司 Diagnostic tool and application method
US11642043B2 (en) 2016-09-16 2023-05-09 Spirox, Inc. Diagnostic tool and method of use
US11957448B2 (en) 2023-04-04 2024-04-16 Spirox, Inc. Diagnostic tool and method of use

Also Published As

Publication number Publication date
US6190328B1 (en) 2001-02-20
FR2779932B1 (en) 2000-12-01
BR9917147A (en) 2001-11-27
CA2275209A1 (en) 1999-12-18
US6409676B2 (en) 2002-06-25
JP2000023926A (en) 2000-01-25
AR018900A1 (en) 2001-12-12
FR2779932A1 (en) 1999-12-24
EP0965306A1 (en) 1999-12-22

Similar Documents

Publication Publication Date Title
US6409676B2 (en) Process for determining respiratory phases of the sleep of a user
US11759590B2 (en) Method and apparatus for improved flow limitation detection of obstructive sleep apnea
US11717626B2 (en) Automated control for detection of flow limitation
US10874328B2 (en) Detection of sleep condition
US20190358419A1 (en) System and Method for Diagnosis and Treatment of a Breathing Pattern of a Patient
JP3566285B2 (en) Automatic CPAP system
US6363933B1 (en) Apparatus and method for controlling the administration of CPAP treatment
JP4960964B2 (en) Systems and methods for diagnosis and treatment of patient breathing patterns
US20050020932A1 (en) Apnea/hypopnea detection system and method
JPH07507466A (en) Breathing assistance devices specifically to treat sleep apnea
US9533115B2 (en) System and method for diagnosis and treatment of a breathing pattern of a patient
AU2015204360B2 (en) Method and Apparatus for Improved Flow Limitation Detection of Obstructive Sleep Apnea
AU2012258376B2 (en) Method and Apparatus for Improved Flow Limitation Detection of Obstructive Sleep Apnea

Legal Events

Date Code Title Description
REMI Maintenance fee reminder mailed
LAPS Lapse for failure to pay maintenance fees
STCH Information on status: patent discontinuation

Free format text: PATENT EXPIRED DUE TO NONPAYMENT OF MAINTENANCE FEES UNDER 37 CFR 1.362

FP Lapsed due to failure to pay maintenance fee

Effective date: 20060625